Peptide encyclopedia

52 peptides across 10 categories — each with mechanism, evidence level, regulatory status, and the protocols reported in the research literature.

Suggested for you

These are popular starting points. Create an account to personalize them to your goals.

Goal

Recovery & Healing

7

Growth Hormone Secretagogues

10

CJC-1295 + Ipamorelin

CJC/Ipa stack

A commonly studied stack pairing a GHRH analogue (CJC-1295) with a selective GH secretagogue (Ipamorelin) to raise growth-hormone pulses.

Moderate evidenceResearch peptide — not FDA-approved

CJC-1295 with DAC

CJC-1295 DAC

A long-acting GHRH analogue with a Drug Affinity Complex that extends its half-life to several days.

Emerging evidenceResearch peptide — not FDA-approved

GHRP-2

Pralmorelin

A growth-hormone-releasing peptide studied for strong GH stimulation, also used clinically as a diagnostic agent in some regions.

Moderate evidenceResearch peptide — not FDA-approved

GHRP-6

Growth Hormone Releasing Peptide 6

An early growth-hormone-releasing peptide noted for pronounced appetite stimulation alongside GH release.

Moderate evidenceResearch peptide — not FDA-approved

Hexarelin

Examorelin

A potent GH-releasing peptide studied for strong GH stimulation and possible cardiac effects.

Emerging evidenceResearch peptide — not FDA-approved

HGH Fragment 176-191

AOD fragment

A fragment of growth hormone studied specifically for fat metabolism without the broader GH effects.

Emerging evidenceResearch peptide — not FDA-approved

Ipamorelin

NNC 26-0161

A selective GH secretagogue peptide known for a clean profile with minimal effect on cortisol or prolactin.

Moderate evidenceResearch peptide — not FDA-approved

MK-677 (Ibutamoren)

Ibutamoren

An orally active, non-peptide ghrelin-receptor agonist studied for sustained increases in GH and IGF-1.

Moderate evidenceResearch peptide — not FDA-approved

Sermorelin

GHRH 1-29

A GHRH analogue historically used clinically to assess and stimulate natural growth-hormone production.

Moderate evidencePrescription only

Tesamorelin

Egrifta

An FDA-approved GHRH analogue indicated to reduce excess visceral abdominal fat in HIV-associated lipodystrophy.

Established evidenceFDA-approved

Metabolic & Weight

8

Longevity & Cellular

7

Cognitive & Mood

6

Immune

4

Sexual Health

1

Skin & Hair

5

Hormonal Axis

3

Sleep / Circadian

1